Literature DB >> 14978106

Essential involvement of IFN-gamma in Clostridium difficile toxin A-induced enteritis.

Yuko Ishida1, Tsuneo Maegawa, Toshikazu Kondo, Akihiko Kimura, Yoichiro Iwakura, Shinichi Nakamura, Naofumi Mukaida.   

Abstract

Clostridium difficile has emerged as the important causative agent of antibiotics-associated pseudomembranous colitis; especially its toxin A is presumed to be responsible for the colitis. We examined the pathophysiological roles of IFN-gamma in toxin A-induced enteritis using IFN-gamma knockout (KO) mice. When toxin A of C. difficile was injected into the ileal loops of BALB/c wild-type (WT) mice, massive fluid secretion, disruption of intestinal epithelial structure, and massive neutrophil infiltration developed within 4 h after the injection. IFN-gamma protein was faintly detected in some CD3-positive lymphocytes in the lamina propria and submucosa of the ileum of untreated WT mice. On the contrary, at 2 and 4 h after toxin A injection, IFN-gamma protein was detected in infiltrating neutrophils and to a lesser degree in CD3-positive lymphocytes. In the ileum of WT mice, toxin A treatment markedly enhanced the gene expression of TNF-alpha, macrophage inflammatory protein-1alpha and -2, KC, and ICAM-1 >2 h after treatment. In contrast, the histopathological changes were marginal, without enhanced fluid secretion in the ileum of toxin A-treated IFN-gamma KO mice. Moreover, toxin A-induced gene expression of TNF-alpha, neutrophil chemotactic chemokines, and ICMA-1 was remarkably attenuated in IFN-gamma KO mice. Furthermore, pretreatment of WT mice with a neutralizing anti-IFN-gamma Ab prevented toxin A-induced enteritis. These observations indicate that IFN-gamma is the crucial mediator of toxin A-induced acute enteritis and suggest that IFN-gamma is an important molecular target for the control of C. difficile-associated pseudomembranous colitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978106     DOI: 10.4049/jimmunol.172.5.3018

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

Review 1.  Considering the Immune System during Fecal Microbiota Transplantation for Clostridioides difficile Infection.

Authors:  Alyse L Frisbee; William A Petri
Journal:  Trends Mol Med       Date:  2020-02-17       Impact factor: 11.951

2.  Murine model of Clostridium difficile infection with aged gnotobiotic C57BL/6 mice and a BI/NAP1 strain.

Authors:  S W Pawlowski; G Calabrese; G L Kolling; J Platts-Mills; R Freire; C AlcantaraWarren; B Liu; R B Sartor; R L Guerrant
Journal:  J Infect Dis       Date:  2010-10-26       Impact factor: 5.226

3.  Clostridium difficile-induced colitis in mice is independent of leukotrienes.

Authors:  Bruno C Trindade; Casey M Theriot; Jhansi L Leslie; Paul E Carlson; Ingrid L Bergin; Marc Peters-Golden; Vincent B Young; David M Aronoff
Journal:  Anaerobe       Date:  2014-09-16       Impact factor: 3.331

4.  A human gut ecosystem protects against C. difficile disease by targeting TcdA.

Authors:  Sarah Lynn Martz; Mabel Guzman-Rodriguez; Shu-Mei He; Curtis Noordhof; David John Hurlbut; Gregory Brian Gloor; Christian Carlucci; Scott Weese; Emma Allen-Vercoe; Jun Sun; Erika Chiong Claud; Elaine Olga Petrof
Journal:  J Gastroenterol       Date:  2016-06-21       Impact factor: 7.527

5.  Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.

Authors:  Mi Na Kim; Seong-Joon Koh; Jung Mogg Kim; Jong Pil Im; Hyun Chae Jung; Joo Sung Kim
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

6.  Distinct roles of helper T-cell subsets in a systemic autoimmune disease.

Authors:  Katrina K Hoyer; Wilson F Kuswanto; Eugenio Gallo; Abul K Abbas
Journal:  Blood       Date:  2008-09-24       Impact factor: 22.113

7.  Tryptophan catabolism restricts IFN-γ-expressing neutrophils and Clostridium difficile immunopathology.

Authors:  Mohamad El-Zaatari; Yu-Ming Chang; Min Zhang; Matthew Franz; Andrew Shreiner; Andrew J McDermott; Koenraad F van der Sluijs; René Lutter; Helmut Grasberger; Nobuhiko Kamada; Vincent B Young; Gary B Huffnagle; John Y Kao
Journal:  J Immunol       Date:  2014-06-16       Impact factor: 5.422

8.  Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection.

Authors:  Rana E El Feghaly; Jennifer L Stauber; Elena Deych; Carlos Gonzalez; Phillip I Tarr; David B Haslam
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

9.  Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.

Authors:  Simon A Hirota; Vadim Iablokov; Sarah E Tulk; L Patrick Schenck; Helen Becker; Jimmie Nguyen; Samir Al Bashir; Tanis C Dingle; Austin Laing; Jianrui Liu; Yan Li; Jeff Bolstad; George L Mulvey; Glen D Armstrong; Wallace K MacNaughton; Daniel A Muruve; Justin A MacDonald; Paul L Beck
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

10.  Monocyte human leukocyte antigen-DR expression-a tool to distinguish intestinal bacterial infections from inflammatory bowel disease?

Authors:  Wolfgang Tillinger; Ruth Jilch; Thomas Waldhoer; Walter Reinisch; Wolfgang Junger
Journal:  Shock       Date:  2013-08       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.